(Q41223326)

28 September 2017

1 reference

title

Increased potency of vanadium using organic ligands (English)

1 reference

28 September 2017

4

1 reference

28 September 2017

J H McNeill

1

1 reference

28 September 2017

V G Yuen

series ordinal

2

1 reference

28 September 2017

S Dai

series ordinal

3

1 reference

28 September 2017

publication date

1 December 1995

1 reference

Molecular and Cellular Biochemistry

28 September 2017

published in

1 reference

28 September 2017

volume

153

1 reference

28 September 2017

issue

1-2

1 reference

28 September 2017

page(s)

175-180

1 reference

Effect of vanadate on the cellular accumulation of pp15, an apparent product of insulin receptor tyrosine kinase action

28 September 2017

cites work

1 reference

12 December 2020

The Spontaneously Diabetic Wistar Rat: Metabolic and Morphologic Studies

1 reference

12 December 2020

Fructose-induced insulin resistance and hypertension in rats

1 reference

12 December 2020

One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate

1 reference

12 December 2020

Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate.

1 reference

12 December 2020

Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV)

1 reference

12 December 2020

Vanadyl sulfate lowers plasma insulin and blood pressure in spontaneously hypertensive rats.

1 reference

12 December 2020

Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats

1 reference

12 December 2020

Insulinomimetic properties of trace elements and characterization of their in vivo mode of action

1 reference

12 December 2020

Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle

1 reference

12 December 2020

Subtotal pancreatectomy in five different rat strains: incidence and course of development of diabetes.

1 reference

12 December 2020

Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats.

1 reference

12 December 2020

The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin-like effect on tyrosine phosphorylation

1 reference

12 December 2020

Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV)

1 reference

12 December 2020

Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats

1 reference

12 December 2020

Oral vanadyl sulfate in treatment of diabetes mellitus in rats

1 reference

12 December 2020

Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in spontaneous hypertensive and Wistar-Kyoto rats

1 reference

12 December 2020

Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase

1 reference

12 December 2020

Insulin-like effect of vanadate on adipocyte glycogen synthase and on phosphorylation of 95,000 dalton subunit of insulin receptor

1 reference

12 December 2020

Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions

1 reference

12 December 2020

A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes

1 reference

12 December 2020

Enhanced glucose tolerance in spontaneously hypertensive rats. Pancreatic beta-cell hyperfunction with normal insulin sensitivity

1 reference

12 December 2020

Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration

1 reference

12 December 2020

Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats

1 reference

12 December 2020

Vanadium--toxicity, metabolism, carrier state

1 reference

12 December 2020

Clearance and distribution of intratracheally instilled vanadium compounds in the rat

1 reference

12 December 2020

Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes

1 reference

12 December 2020

Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats

1 reference

12 December 2020

Diabetogenic action of streptozotocin: relationship of dose to metabolic response

1 reference

12 December 2020

Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment

1 reference

12 December 2020

Bis(maltolato)oxovanadium(IV) is a potent insulin mimic

1 reference

12 December 2020

Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.

1 reference

12 December 2020

Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins

1 reference

12 December 2020

Mechanisms of Action of Vanadium

1 reference

12 December 2020

One-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate did not alter blood pressure or haematological indices

1 reference

12 December 2020

Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats.

1 reference

12 December 2020

Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate

1 reference

12 December 2020

In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes

1 reference

12 December 2020

Insulin-like effects of vanadate in isolated rat adipocytes

1 reference

12 December 2020

Concentration-dependent glucose-lowering effects of oral vanadyl are maintained following treatment withdrawal in streptozotocin-diabetic rats

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01075935

1 reference

28 September 2017

1 reference